نتایج جستجو برای: trough plasma concentration

تعداد نتایج: 699116  

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2013
S J Seong M Lim S K Sohn J H Moon S-J Oh B S Kim H M Ryoo J S Chung Y D Joo S M Bang C W Jung D H Kim S Y Park S S Yoon I Kim H G Lee J H Won Y H Min J W Cheong J S Park K S Eom M S Hyun M K Kim H Kim M R Park J Park C S Kim H J Kim Y K Kim E K Park D Y Zang D Y Jo H W Lee Y-R Yoon

BACKGROUND This study explored the impact of genetic polymorphisms in cytochrome P450 (CYP) enzymes and transporters on the plasma trough concentration of imatinib mesylate (IM) and clinical response in chronic myeloid leukemia (CML). PATIENTS AND METHODS In total, 82 patients with CML who had been administered 400 mg IM daily for over 6 months were genotyped for 11 single-nucleotide polymorp...

Journal: :Journal of immunological methods 2009
David Jamieson Nicola Cresti Mark W Verrill Alan V Boddy

Trastuzumab is a therapeutic monoclonal antibody against the Her2 oncoprotein, which is over-expressed in approximately 30% of breast cancers, and is now used routinely in the management of early and metastatic Her2+ disease. However, not all Her2+ breast cancer patients respond to trastuzumab and the pharmacodynamic and pharmacokinetic parameters behind this variation in response are unknown. ...

Vancomycin susceptibility of methicillin-resistant Staphylococcus aureus has been changed over time and its average minimum inhibitory concentration increased from 1.5 to 1.75 mg/L. A recently published guideline by the American Society of Health Pharmacist recommended a daily dose of 15-20 mg/kg every 8 to 12 hours of vancomycin to achieve a trough concentration between 15-20 mg/L for treatmen...

Journal: :Biological & pharmaceutical bulletin 2013
Kazuaki Matsumoto Naoko Kanazawa Erika Watanabe Yuta Yokoyama Tomohide Fukamizu Yoshihiro Shimodozono Chiharu Maeda Tomotsugu Yasuda Yasuyuki Kakihana Kazuro Ikawa Norifumi Morikawa Yasuo Takeda

Methicillin-resistant Staphylococcus aureus (MRSA) is now endemic in many hospitals. Infection with MRSA is more frequent in the intensive care unit (ICU) than in general wards. Therefore, appropriate treatments for MRSA infections will lead to good outcomes in the ICU. Teicoplanin is an anti-MRSA agent. Recently, it was recommended at a new target trough concentration of 15-30 µg/mL. However, ...

Journal: :South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2012
J Y Cheong M Makmor-Bakry C L Lau R Abdul Rahman

OBJECTIVES The incidence of methicillin-resistant Staphylococcus aureus (MRSA) infections in intensive care units in Malaysia is significant. Invasive MRSA infections are commonly treated with vancomycin. In clinical practice, the serum vancomycin trough concentration is used as a surrogate marker of vancomycin efficacy. A low concentration of vancomycin may result in less effective therapy and...

Journal: :Antimicrobial agents and chemotherapy 2001
M A Boogaerts J Maertens R Van Der Geest A Bosly J M Michaux A Van Hoof M Cleeren R Wostenborghs K De Beule

The pharmacokinetics and safety of an intravenous hydroxypropyl-beta-cyclodextrin solution of itraconazole administered for 7 days followed by itraconazole oral solution administered at 200 mg once or twice daily for 14 days were assessed in 17 patients with hematologic malignancies. Steady-state plasma itraconazole concentrations were reached by 48 h after the start of intravenous treatment. T...

2006
Peter C. Adamson Frank M. Balis James Miser Carola Arndt Robert J. Wells Andrea Gillespie Leslie Aronson John S. Penta Neil J. Clendeninn David G. Poplack

Piritrexim, an orally administered, lipid-soluble antifolate, was evalu ated in a multi-institutional phase I trial in children. The starting dose was 10 mg/m2/dose administered every 8 h daily for 5 days for 3 consecutive weeks, with dose escalations in increments of 5 mg/m2/dose. Eighteen patients (16 with metastatic sarcoma, 1 with acute lymphoblastic leukemia, and 1 with a brainstem glioma)...

Journal: :Cancer research 1992
P C Adamson F M Balis J Miser C Arndt R J Wells A Gillespie L Aronson J S Penta N J Clendeninn D G Poplack

Piritrexim, an orally administered, lipid-soluble antifolate, was evaluated in a multi-institutional phase I trial in children. The starting dose was 10 mg/m2/dose administered every 8 h daily for 5 days for 3 consecutive weeks, with dose escalations in increments of 5 mg/m2/dose. Eighteen patients (16 with metastatic sarcoma, 1 with acute lymphoblastic leukemia, and 1 with a brainstem glioma),...

2017
Vidya Mave Aarti Kinikar Anju Kagal Smita Nimkar Hari Koli Sultanat Khwaja Renu Bharadwaj Roy Gerona Anita Wen Geetha Ramachandran Hemanth Kumar Peter Bacchetti Kelly E Dooley Nikhil Gupte Amita Gupta Monica Gandhi

We measured hair and plasma concentrations of isoniazid among sixteen children with tuberculosis who underwent personal or video-assisted directly observed therapy and thus had 100% adherence. This study therefore defined typical isoniazid exposure parameters after two months of treatment among fully-adherent patients in both hair and plasma (plasma area under the concentration-time curve, AUC,...

Journal: :Journal of acquired immune deficiency syndromes 2006
Alan Winston Nimesh Patel David Back Saye Khoo Steve Bulbeck Sundhiya Mandalia Anton L Pozniak Mark Nelson Graeme Moyle Brian Gazzard Marta Boffito

In individuals with incomplete suppression of HIV replication, a major clinical challenge is to establish which agents retain significant antiviral activity. Measurements of both plasma concentration and resistance of selected antiretro-viral agents are widely available. Clinical studies have shown short-term virologic benefit associated with the use of resistance testing in drug-experienced pa...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید